1 study found for:    24002496 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Phase I Study of AC220 in Patients With Relapsed/Refractory Acute Myeloid Leukemia Regardless of FLT3 Status
Conditions: Acute Myeloid Leukemia;   Leukemia;   Myelodysplastic Syndrome;   AML;   MDS
Intervention: Drug: AC220

Indicates status has not been verified in more than two years